Genetics of Human Obesity

Nutrition in the Prevention and Treatment of Disease

Volumn , Issue , 2013, Pages 427-444

  Fisler, Janis S ^a   Warden, Craig H ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84881614627     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-391884-0.00023-8     Document Type: Chapter

References (146)

1. Bouchard C., Perusse L., Rice T., Rao D.C. The genetics of human obesity. Handbook of Obesity 1998, 157-190. Dekker, New York. G.A. Bray, C. Bouchard, W.P.T. James (Eds.).
2. O'Rahilly S., Farooqi S. Genetics of obesity. Philos. Trans. R. Soc. London B 2006, 361:1095-1105.
3. Faith M.S., Pietrobelli A., Nunez C., Heo M., Heymsfield S.B., Allison D.B. Evidence for independent genetic influences on fat mass and body mass index in a pediatric twin sample. Pediatrics 1999, 104:61-67.
4. Butte N.F., Cai G., Cole S.A., Comuzzie A.G. Viva la familia study: genetic and environmental contributions to childhood obesity and its comorbidities in the Hispanic population. Am. J. Clin. Nutr. 2006, 84:646-654.
5. Comuzzie A.G., Allison D.B. The search for human obesity genes. Science 1998, 280:1374-1377.
6. Reed D.R., Lawler M.P., Tordoff M.G. Reduced body weight is a common effect of gene knockout in mice. BMC Genetics 2008, 9:4.
7. Speliotes E.K., Willer C.J., Berndt S.I., Monda K.L., Thorleifsson G., Jackson A.U., et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat. Genet. 2010, 42:937-948.
8. Yang X., Deignan J.L., Qi H., Zhu J., Qian S., Zhong J., et al. Validation of candidate causal genes for obesity that affect shared metabolic pathways and networks. Nat. Genet. 2009, 41:415-423.
9. Greenawalt D.M., Dobrin R., Chudin E., Hatoum I.J., Suver C., Beaulaurier J., et al. A survey of the genetics of stomach, liver, and adipose gene expression from a morbidly obese cohort. Genome Res. 2011, 21:1008-1016.
10. Zhong H., Yang X., Kaplan L.M., Molony C., Schadt E.E. Integrating pathway analysis and genetics of gene expression for genome-wide association studies. Am. J. Hum. Genet. 2010, 86:581-591.
11. Warden C.H., Fisler J.S. Molecular genetics of obesity. Handbook of Obesity 1998, 223-242. Dekker, New York. G.A. Bray, C. Bouchard, W.P.T. James (Eds.).
12. Silver L.M. Mouse Genetics 1995, Oxford University Press, New York.
13. Rankinen T., Zuberi A., Chagnon Y.C., Weisnagel S.J., Argyropoulos G., Walts B., et al. The human obesity gene map: the 2005 update. Obesity (Silver Spring) 2006, 14:529-644.
14. Lembertas A.V., Perusse L., Chagnon Y.C., Fisler J.S., Warden C.H., Purcell-Huynh D.A., et al. Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q. J. Clin. Invest. 1997, 100:1240-1247.
15. Lee J.H., Reed D.R., Li W.D., Xu W., Joo E.J., Kilker R.L., et al. Genome scan for human obesity and linkage to markers in 20q13. Am. J. Hum. Genet. 1999, 64:196-209.
16. Haseman J.K., Elston R.C. The investigation of linkage between a quantitative trait and a marker locus. Behav. Genet. 1972, 2:3-19.
17. Kruglyak L., Lander E.S. High-resolution genetic mapping of complex traits. Am. J. Hum. Genet. 1995, 56:1212-1223.
18. Herbert A., Gerry N.P., McQueen M.B., Heid I.M., Pfeufer A., Illig T., et al. Response to comments on "A common genetic variant is associated with adult and childhood obesity,". Science 2007, 315:187e.
19. Glaser S., Anastassiadis K., Stewart A.F. Current issues in mouse genome engineering. Nat. Genet. 2005, 37:1187-1193.
20. McMinn J.E., Liu S.M., Liu H., Dragatsis I., Dietrich P., Ludwig T., et al. Neuronal deletion of Lepr elicits diabesity in mice without affecting cold tolerance or fertility. Am. J. Physiol. Endocrinol. Metab. 2005, 289:E403-E411.
21. Bachman E.S., Dhillon H., Zhang C.Y., Cinti S., Bianco A.C., Kobilka B.K., et al. betaAR signaling required for diet-induced thermogenesis and obesity resistance. Science 2002, 297:843-845.
22. Goldstein D.B. Common genetic variation and human traits. N. Engl. J. Med. 2009, 360:1696-1698.
23. Frayling T.M., Timpson N.J., Weedon M.N., Zeggini E., Freathy R.M., Lindgren C.M., et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007, 316:889-894.
24. Maher B. Personal genomes: the case of the missing heritability. Nature 2008, 456:18-21.
25. Eichler E.E., Flint J., Gibson G., Kong A., Leal S.M., Moore J.H., et al. Missing heritability and strategies for finding the underlying causes of complex disease. Nat. Rev. Genet. 2010, 11:446-450.
26. Heng H.H. Missing heritability and stochastic genome alterations. Nat. Rev. Genet. 2010, 11:813.
27. Bhatia G., Bansal V., Harismendy O., Schork N.J., Topol E.J., Frazer K., et al. A covering method for detecting genetic associations between rare variants and common phenotypes. PLoS Comput. Biol. 2010, 6:e1000954.
28. Manolio T.A., Collins F.S., Cox N.J., Goldstein D.B., Hindorff L.A., Hunter D.J., et al. Finding the missing heritability of complex diseases. Nature 2009, 461:747-753.
29. Blakemore A.I., Meyre D., Delplanque J., Vatin V., Lecoeur C., Marre M., et al. A rare variant in the visfatin gene (NAMPT/PBEF1) is associated with protection from obesity. Obesity 2009, 17:1549-1553.
30. Walters R.G., Jacquemont S., Valsesia A., de Smith A.J., Martinet D., Andersson J., et al. A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature 2010, 463:671-675.
31. Bulik C.M., Allison D.B. The genetic epidemiology of thinness. Obes. Rev. 2001, 2:107-115.
32. Bochukova E.G., Huang N., Keogh J., Henning E., Purmann C., Blaszczyk K., et al. Large, rare chromosomal deletions associated with severe early-onset obesity. Nature 2010, 463:666-670.
33. Glessner J.T., Bradfield J.P., Wang K., Takahashi N., Zhang H., Sleiman P.M., et al. A genome-wide study reveals copy number variants exclusive to childhood obesity cases. Am. J. Hum. Genet. 2010, 87:661-666.
34. Kong A., Steinthorsdottir V., Masson G., Thorleifsson G., Sulem P., Besenbacher S., et al. Parental origin of sequence variants associated with complex diseases. Nature 2009, 462:868-874.
35. Warden C.H., Fisler J.S. Obesity: from animal models to human genetics to practical applications. Prog. Mol. Biol. Transl. Sci. 2010, 94:373-389.
36. Yazbek S.N., Spiezio S.H., Nadeau J.H., Buchner D.A. Ancestral paternal genotype controls body weight and food intake for multiple generations. Hum. Mol. Genet. 2010, 19:4134-4144.
37. Ng S.F., Lin R.C., Laybutt D.R., Barres R., Owens J.A., Morris M.J. Chronic high-fat diet in fathers programs beta-cell dysfunction in female rat offspring. Nature 2010, 467:963-966.
38. Skinner M.K. Metabolic disorders: Fathers' nutritional legacy. Nature 2010, 467:922-923.
39. Ahmed F. Epigenetics: tales of adversity. Nature 2010, 468:S20.
40. Schulz L.C. The Dutch Hunger Winter and the developmental origins of health and disease. Proc. Natl. Acad. Sci. USA 2010, 107:16757-16758.
41. Wang Y., Wang X., Kong Y., Zhang J.H., Zeng Q. The Great Chinese Famine leads to shorter and overweight females in Chongqing Chinese population after 50 years. Obesity 2010, 18:588-592.
42. Tobi E.W., Lumey L.H., Talens R.P., Kremer D., Putter H., Stein A.D., et al. DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific. Hum. Mol. Genet. 2009, 18:4046-4053.
43. Moore J.H. The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum. Hered. 2003, 56:73-82.
44. Warden C.H., Yi N., Fisler J. Epistasis among genes is a universal phenomenon in obesity: evidence from rodent models. Nutrition 2004, 20:74-77.
45. Hummel K.P., Coleman D.L., Lane P.W. The influence of genetic background on expression of mutations at the diabetes locus in the mouse: I. C57BL-KsJ and C57BL-6J strains. Biochem. Genet. 1972, 7:1-13.
46. Feitosa M.F., North K.E., Myers R.H., Pankow J.S., Borecki I.B. Evidence for three novel QTLs for adiposity on chromosome 2 with epistatic interactions: The NHLBI Family Heart Study. Obesity 2009, 17:2190-2195.
47. Dong C., Wang S., Li W.D., Li D., Zhao H., Price R.A. Interacting genetic loci on chromosomes 20 and 10 influence extreme human obesity. Am. J. Hum. Genet. 2003, 72:115-124.
48. Skibola C.F., Holly E.A., Forrest M.S., Hubbard A., Bracci P.M., Skibola D.R., et al. Body mass index, leptin and leptin receptor polymorphisms, and non-Hodgkin lymphoma. Cancer Epidemiol. Biomarkers Prev. 2004, 13:779-786.
49. Ellsworth D.L., Coady S.A., Chen W., Srinivasan S.R., Boerwinkle E., Berenson G.S. Interactive effects between polymorphisms in the beta-adrenergic receptors and longitudinal changes in obesity. Obes. Res. 2005, 13:519-526.
50. Angeli C.B., Kimura L., Auricchio M.T., Vicente J.P., Mattevi V.S., Zembrzuski V.M., et al. Multilocus analyses of seven candidate genes suggest interacting pathways for obesity-related traits in Brazilian populations. Obesity 2011, 19:1244-1251.
51. Ukkola O., Perusse L., Chagnon Y.C., Despres J.P., Bouchard C. Interactions among the glucocorticoid receptor, lipoprotein lipase and adrenergic receptor genes and abdominal fat in the Quebec Family Study. Int. J. Obes. Relat. Metab. Disord. 2001, 25:1332-1339.
52. Ravussin E., Danforth E. Beyond sloth-Physical activity and weight gain. Science 1999, 283:184-185.
53. Sims E.A., Danforth E., Horton E.S., Bray G.A., Glennon J.A., Salans L.B. Endocrine and metabolic effects of experimental obesity in man. Recent Prog. Horm. Res. 1973, 29:457-496.
54. Sims E.A., Goldman R.F., Gluck C.M., Horton E.S., Kelleher P.C., Rowe D.W. Experimental obesity in man. Trans. Assoc. Am. Physicians 1968, 81:153-170.
55. Bouchard C., Tremblay A., Despres J.P., Nadeau A., Lupien P.J., Theriault G., et al. The response to long-term overfeeding in identical twins. N. Engl. J. Med. 1990, 322:1477-1482.
56. Bouchard C., Tremblay A., Despres J.P., Theriault G., Nadeau A., Lupien P.J., et al. The response to exercise with constant energy intake in identical twins. Obes. Res. 1994, 2:400-410.
57. Levine J.A., Eberhardt N.L., Jensen M.D. Role of nonexercise activity thermogenesis in resistance to fat gain in humans. Science 1999, 283:212-214.
58. Ravussin E., Lillioja S., Anderson T.E., Christin L., Bogardus C. Determinants of 24-hour energy expenditure in man: methods and results using a respiratory chamber. J. Clin. Invest. 1986, 78:1568-1578.
59. Zurlo F., Ferraro R.T., Fontvielle A.M., Rising R., Bogardus C., Ravussin E. Spontaneous physical activity and obesity: cross-sectional and longitudinal studies in Pima Indians. Am. J. Physiol. 1992, 263:E296-E300.
60. Grimm E.R., Steinle N.I. Genetics of eating behavior: established and emerging concepts. Nutr. Rev. 2011, 69:52-60.
61. Rankinen T., Bray M.S., Hagberg J.M., Perusse L., Roth S.M., Wolfarth B., et al. The human gene map for performance and health-related fitness phenotypes: the 2005 update. Med. Sci. Sports Exerc. 2006, 38:1863-1888.
62. Warden C.H., Fisler J.S. Gene-nutrient and gene-physical activity summary-Genetics viewpoint. Obesity 2008, 16(Suppl. 3):S55-S59.
63. Farooki I., O'Rahilly S. Genetics of obesity in humans. Endocr. Rev. 2006, 27:710-718.
64. Gray J., Yeo G., Hung C., Keogh J., Clayton P., Banerjee K., et al. Functional characterization of human NTRK2 mutations identified in patients with severe early-onset obesity. Int. J. Obes. (London) 2007, 31:359-364.
65. Farooqi I.S. Genetic and hereditary aspects of childhood obesity. Best Pract. Res. Clin. Endocrinol. Metab. 2005, 19:359-374.
66. Adan R.A., Tiesjema B., Hillebrand J.J., la Fleur S.E., Kas M.J., de Krom M. The MC4 receptor and control of appetite. Br. J. Pharmacol. 2006, 149:815-827.
67. Farooqi I.S., Drop S., Clements A., Keogh J.M., Biernacka J., Lowenbein S., et al. Heterozygosity for a POMC-null mutation and increased obesity risk in humans. Diabetes 2006, 55:2549-2553.
68. Lee Y.S. The role of leptin-melanocortin system and human weight regulation: lessons from experiments of nature. Ann. Acad. Med. Singapore 2009, 38:34-44.
69. Mutch D.M., Clement K. Unraveling the genetics of human obesity. PLoS Genet. 2006, 2:e188.
70. Zigman J.M., Elmquist J.K. Minireview: from anorexia to obesity-The yin and yang of body weight control. Endocrinology 2003, 144:3749-3756.
71. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
72. Halaas J.L., Gajiwala K.S., Maffei M., Cohen S.L., Chait B.T., Rabinowitz D., et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995, 269:543-546.
73. Golden P.L., Maccagnan T.J., Pardridge W.M. Human blood-brain barrier leptin receptor: binding and endocytosis in isolated human brain microvessels. J. Clin. Invest. 1997, 99:14-18.
74. Cohen M.M. Role of leptin in regulating appetite, neuroendocrine function, and bone remodeling. Am. J. Med. Genet. A 2006, 140:515-524.
75. Farooqi I.S., O'Rahilly S. Leptin: a pivotal regulator of human energy homeostasis. Am. J. Clin. Nutr. 2009, 89:980S-984S.
76. Friedman J.M., Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 1998, 395:763-770.
77. Paz-Filho G., Wong M.L., Licinio J. Ten years of leptin replacement therapy. Obes. Rev. 2011, 12:e315-e323.
78. Tartaglia L.A., Dembski M., Weng X., Deng N., Culpepper J., Devos R., et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995, 83:1263-1271.
79. Farooqi I.S., Wangensteen T., Collins S., Kimber W., Matarese G., Keogh J.M., et al. Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N. Engl. J. Med. 2007, 356:237-247.
80. Krude H., Biebermann H., Luck W., Horn R., Brabant G., Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat. Genet. 1998, 19:155-157.
81. Lee Y.S., Challis B.G., Thompson D.A., Yeo G.S., Keogh J.M., Madonna M.E., et al. A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance. Cell Metab. 2006, 3:135-140.
82. Lubrano-Berthelier C., Dubern B., Lacorte J.M., Picard F., Shapiro A., Zhang S., et al. Melanocortin 4 receptor mutations in a large cohort of severely obese adults: prevalence, functional classification, genotype-phenotype relationship, and lack of association with binge eating. J. Clin. Endocrinol. Metab. 2006, 91:1811-1818.
83. Santoro N., Perrone L., Cirillo G., Raimondo P., Amato A., Brienza C., et al. Effect of the melanocortin-3 receptor C17A and G241A variants on weight loss in childhood obesity. Am. J. Clin. Nutr. 2007, 85:950-953.
84. Hung C.C., Luan J., Sims M., Keogh J.M., Hall C., Wareham N.J., et al. Studies of the SIM1 gene in relation to human obesity and obesity-related traits. Int. J. Obes. (London) 2007, 31:429-434.
85. Gray J., Yeo G.S., Cox J.J., Morton J., Adlam A.L., Keogh J.M., et al. Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes 2006, 55:3366-3371.
86. Must A., Spadano J., Coakley E.H., Field A.E., Colditz G., Dietz W.H. The disease burden associated with overweight and obesity. JAMA 1999, 282:1523-1529.
87. Roth H., Korn T., Rosenkranz K., Hinney A., Ziegler A., Kunz J., et al. Transmission disequilibrium and sequence variants at the leptin receptor gene in extremely obese German children and adolescents. Hum. Genet. 1998, 103:540-546.
88. de Silva A.M., Walder K.R., Aitman T.J., Gotoda T., Goldstone A.P., Hodge A.M., et al. Combination of polymorphisms in OB-R and the OB gene associated with insulin resistance in Nauruan males. Int. J. Obes. Relat. Metab. Disord. 1999, 23:816-822.
89. Yu Z., Han S., Cao X., Zhu C., Wang X., Guo X. Genetic polymorphisms in adipokine genes and the risk of obesity: a systematic review and meta-analysis. Obesity 2012, 20:396-406.
90. Fawcett K.A., Barroso I. The genetics of obesity: FTO leads the way. Trends Genet. 2010, 26:266-274.
91. Razquin C., Marti A., Martinez J.A. Evidences on three relevant obesogenes: MC4R, FTO and PPARgamma. Approaches for personalized nutrition. Mol. Nutr. Food Res. 2011, 55:136-149.
92. Stutzmann F., Cauchi S., Durand E., Calvacanti-Proenca C., Pigeyre M., Hartikainen A.L., et al. Common genetic variation near MC4R is associated with eating behaviour patterns in European populations. Int. J. Obes. 2009, 33:373-378.
93. Frayling T.M., Timpson N.J., Weedom M.N., Zeggini E., Freathy R.M., Lindgren C.M., et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007, 316:889-894.
94. Gerken T., Girard C.A., Tung Y.C., Webby C.J., Saudek V., Hewitson K.S., et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 2007, 318:1469-1472.
95. Sonestedt E., Roos C., Gullberg B., Ericson U., Wirfalt E., Orho-Melander M. Fat and carbohydrate intake modify the association between genetic variation in the FTO genotype and obesity. Am. J. Clin. Nutr. 2009, 90:1418-1425.
96. Chu X., Erdman R., Susek M., Gerst H., Derr K., Al-Agha M., et al. Association of morbid obesity with FTO and INSIG2 allelic variants. Arch. Surg. 2008, 143:235-240.
97. Cauchi S., Stutzmann F., Cavalcanti-Proenca C., Durand E., Pouta A., Hartikainen A.L., et al. Combined effects of MC4R and FTO common genetic variants on obesity in European general populations. J. Mol. Med. 2009, 87:537-546.
98. Loos R.J., Ruchat S., Rankinen T., Tremblay A., Perusse L., Bouchard C. Adiponectin and adiponectin receptor gene variants in relation to resting metabolic rate, respiratory quotient, and adiposity-related phenotypes in the Quebec Family Study. Am. J. Clin. Nutr. 2007, 85:26-34.
99. Ishiyama-Shigemoto S., Yamada K., Yuan X., Ichikawa F., Nonaka K. Association of polymorphisms in the beta2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Diabetologia 1999, 42:98-101.
100. Large V., Hellstrom L., Reynisdottir S., Lonnqvist F., Eriksson P., Lannfelt L., et al. Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. J. Clin. Invest. 1997, 100:3005-3013.
101. Mori Y., Kim-Motoyama H., Ito Y., Katakura T., Yasuda K., Ishiyama-Shigemoto S., et al. The Gln27Glu beta2-adrenergic receptor variant is associated with obesity due to subcutaneous fat accumulation in Japanese men. Biochem. Biophys. Res. Commun. 1999, 258:138-140.
102. Jalba M.S., Rhoads G.G., Demissie K. Association of codon 16 and codon 27 beta 2-adrenergic receptor gene polymorphisms with obesity: a meta-analysis. Obesity 2008, 16:2096-2106.
103. Susulic V.S., Frederich R.C., Lawitts J., Tozzo E., Kahn B.B., Harper M.E., et al. Targeted disruption of the beta 3-adrenergic receptor gene. J. Biol. Chem. 1995, 270:29483-29492.
104. Allison D.B., Heo M., Faith M.S., Pietrobelli A. Meta-analysis of the association of the Trp64Arg polymorphism in the beta3 adrenergic receptor with body mass index. Int. J. Obes. Relat. Metab. Disord. 1998, 22:559-566.
105. Clarke S.D., Thuillier P., Baillie R.A., Sha X. Peroxisome proliferator-activated receptors: a family of lipid-activated transcription factors. Am. J. Clin. Nutr. 1999, 70:566-571.
106. Ristow M., Muller-Wieland D., Pfeiffer A., Krone W., Kahn C.R. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N. Engl. J. Med. 1998, 339:953-959.
107. Memisoglu A., Hu F.B., Hankinson S.E., Manson J.E., De Vivo I., Willett W.C., et al. Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass. Hum. Mol. Genet. 2003, 12:2923-2929.
108. Robitaille J., Despres J.P., Perusse L., Vohl M.C. The PPAR-gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: results from the Quebec Family Study. Clin. Genet. 2003, 63:109-116.
109. Razquin C., Alfredo Martinez J., Martinez-Gonzalez M.A., Corella D., Santos J.M., Marti A. The Mediterranean diet protects against waist circumference enlargement in 12Ala carriers for the PPARgamma gene: 2 years' follow-up of 774 subjects at high cardiovascular risk. Br. J. Nutr. 2009, 102:672-679.
110. Deeb S.S., Fajas L., Nemoto M., Pihlajamaki J., Mykkanen L., Kuusisto J., et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat. Genet. 1998, 20:284-287.
111. Bouchard C., Perusse L., Chagnon Y.C., Warden C., Ricquier D. Linkage between markers in the vicinity of the uncoupling protein 2 gene and resting metabolic rate in humans. Hum. Mol. Genet. 1997, 6:1887-1889.
112. Walder K., Norman R.A., Hanson R.L., Schrauwen P., Neverova M., Jenkinson C.P., et al. Association between uncoupling protein polymorphisms (UCP2-UCP3) and energy metabolism/obesity in Pima Indians. Hum. Mol. Genet. 1998, 7:1431-1435.
113. Cassell P.G., Neverova M., Janmohamed S., Uwakwe N., Qureshi A., McCarthy M.I., et al. An uncoupling protein 2 gene variant is associated with a raised body mass index but not Type II diabetes. Diabetologia 1999, 42:688-692.
114. Klannemark M., Orho M., Groop L. No relationship between identified variants in the uncoupling protein 2 gene and energy expenditure. Eur. J. Endocrinol. 1998, 139:217-223.
115. Urhammer S.A., Dalgaard L.T., Sorensen T.I., Moller A.M., Andersen T., Tybjaerg-Hansen A., et al. Mutational analysis of the coding region of the uncoupling protein 2 gene in obese NIDDM patients: impact of a common amino acid polymorphism on juvenile and maturity onset forms of obesity and insulin resistance. Diabetologia 1997, 40:1227-1230.
116. Argyropoulos G., Brown A.M., Willi S.M., Zhu J., He Y., Reitman M., et al. Effects of mutations in the human uncoupling protein 3 gene on the respiratory quotient and fat oxidation in severe obesity and type 2 diabetes. J. Clin. Invest. 1998, 102:1345-1351.
117. Ravussin E. Metabolic differences and the development of obesity. Metabolism 1995, 44:12-14.
118. Jakicic J.M., Wing R.R. Differences in resting energy expenditure in African-American vs Caucasian overweight females. Int. J. Obes. Relat. Metab. Disord. 1998, 22:236-242.
119. Xu K., Zhang M., Cui D., Fu Y., Qian L., Gu R., et al. UCP2 -866G/A and Ala55Val, and UCP3 -55C/T polymorphisms in association with type 2 diabetes susceptibility: a meta-analysis study. Diabetologia 2011, 54:2315-2324.
120. Bray G.A. Classification and evaluation of the overweight patient. Handbook of Obesity 1989, 831-854. Dekker, New York. G.A. Bray, C. Bouchard, W.P.T. James (Eds.).
121. Couper R. Prader-Willi syndrome. J. Paediatr. Child Health 1999, 35:331-334.
122. Khan N.L., Wood N.W. Prader-Willi and Angelman syndromes: update on genetic mechanisms and diagnostic complexities. Curr. Opin. Neurol. 1999, 12:149-154.
123. Croft J.B., Morrell D., Chase C.L., Swift M. Obesity in heterozygous carriers of the gene for the Bardet-Biedl syndrome. Am. J. Med. Genet. 1995, 55:12-15.
124. Marshall J.D., Bronson R.T., Collin G.B., Nordstrom A.D., Maffei P., Paisey R.B., et al. New Alstrom syndrome phenotypes based on the evaluation of 182 cases. Arch. Intern. Med. 2005, 165:675-683.
125. Rivera-Brugues N., Albrecht B., Wieczorek D., Schmidt H., Keller T., Gohring I., et al. Cohen syndrome diagnosis using whole genome arrays. J. Med. Genet. 2011, 48:136-140.
126. Hinney A., Schmidt A., Nottebom K., Heibult O., Becker I., Ziegler A., et al. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J. Clin. Endocrinol. Metab. 1999, 84:1483-1486.
127. Sina M., Hinney A., Ziegler A., Neupert T., Mayer H., Siegfried W., et al. Phenotypes in three pedigrees with autosomal dominant obesity caused by haploinsufficiency mutations in the melanocortin-4 receptor gene. Am. J. Hum. Genet. 1999, 65:1501-1507.
128. Vaisse C., Clement K., Guy-Grand B., Froguel P. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat. Genet. 1998, 20:113-114.
129. Yeo G.S., Farooqi I.S., Aminian S., Halsall D.J., Stanhope R.G., O'Rahilly S. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat. Genet. 1998, 20:111-112.
130. Valve R., Sivenius K., Miettinen R., Pihlajamaki J., Rissanen A., Deeb S.S., et al. Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women. J. Clin. Endocrinol. Metab. 1999, 84:3708-3712.
131. Hixson J.E., Almasy L., Cole S., Birnbaum S., Mitchell B.D., Mahaney M.C., et al. Normal variation in leptin levels in associated with polymorphisms in the proopiomelanocortin gene, POMC. J. Clin. Endocrinol. Metab. 1999, 84:3187-3191.
132. Lander E.S., Schork N.J. Genetic dissection of complex traits. Science 1994, 265:2037-2048.
133. Farooqi I.S., O'Rahilly S. New advances in the genetics of early onset obesity. Int. J. Obes. (London) 2005, 29:1149-1152.
134. Hager J., Clement K., Francke S., Dina C., Raison J., Lahlou N., et al. A polymorphism in the 5′ untranslated region of the human ob gene is associated with low leptin levels. Int. J. Obes. Relat. Metab. Disord. 1998, 22:200-205.
135. Palmer J.S., Duffy D.L., Box N.F., Aitken J.F., O'Gorman L.E., Green A.C., et al. Melanocortin-1 receptor polymorphisms and risk of melanoma: Is the association explained solely by pigmentation phenotype?. Am. J. Hum. Genet. 2000, 66:176-186.
136. Xiang Z., Proneth B., Dirain M.L., Litherland S.A., Haskell-Luevano C. Pharmacological characterization of 30 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists, synthetic agonists, and the endogenous agouti-related protein antagonist. Biochemistry 2010, 49:4583-4600.
137. Nathan P.J., O'Neill B.V., Napolitano A., Bullmore E.T. Neuropsychiatric adverse effects of centrally acting antiobesity drugs. CNS Neurosci. Ther. 2010, 17:490-505.
138. Dietz W.H., Robinson T.N. Clinical practice: overweight children and adolescents. N. Engl. J. Med. 2005, 352:2100-2109.
139. Aslan I.R., Campos G.M., Calton M.A., Evans D.S., Merriman R.B., Vaisse C. Weight loss after Roux-en-Y gastric bypass in obese patients heterozygous for MC4R mutations. Obes. Surg. 2011, 21:930-934.
140. Aslan I.R., Ranadive S.A., Ersoy B.A., Rogers S.J., Lustig R.H., Vaisse C. Bariatric surgery in a patient with complete MC4R deficiency. Int. J. Obes. 2011, 35:457-461.
141. Sarzynski M.A., Jacobson P., Rankinen T., Carlsson B., Sjostrom L., Bouchard C., et al. Associations of markers in 11 obesity candidate genes with maximal weight loss and weight regain in the SOS bariatric surgery cases. Int. J. Obes. 2011, 35:676-683.
142. Still C.D., Wood G.C., Chu X., Erdman R., Manney C.H., Benotti P.N., et al. High allelic burden of four obesity SNPs is associated with poorer weight loss outcomes following gastric bypass surgery. Obesity 2011, 19:1676-1683.
143. Herbert A., Gerry N.P., McQueen M.B., Heid I.M., Pfeufer A., Illig T., et al. A common genetic variant is associated with adult and childhood obesity. Science 2006, 312:279-283.
144. Xu B., Goulding E.H., Zang K., Cepoi D., Cone R.D., Jones K.R., et al. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat. Neurosci. 2003, 6:736-742.
145. Willer C.J., et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat. Genet. 2009, 41:25-34.
146. Gouda H.N., et al. The association between peroxisome proliferator-activated receptor-gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis. Am. J. Epidemiol. 2010, 171:645-655.